Straub Medical @ LINCRotarex®S for in-stent restenosis/occlusion: A French multicentre experience...

2
Rotarex ® S for in-stent restenosis/occlusion: A French multicentre experience with 128 patients I Romaric Loffroy Rotarex ® S for in-stent restenosis/occlusion: The Leipzig experience with more than 300 patients I Bruno Freitas Live Case ISR (Leipzig) Clinical and cost effectiveness of treating bypass occlusion with Rotarex ® S vs. surgery I Bruno Migliara Live Case Native Fempop (Leipzig) SAVioR trial: Acute improvement of vascular function following debulking atherectomy with Rotarex ® S I Christos Rammos … for the treatment of in-stent reocclusion I Bruno Freitas I Wednesday, 09:30 – 1 1 :00 … for the treatment of bypass occlusions I Bruno Migliara I Wednesday, 13:00 – 14:30 www.straubmedical.com | [email protected] Arterial Symposium | Thursday, 09:30 – 11 :00 | Main Arena 1, Room 1 Hands-on Workshop | Tips and Tricks … | @ Straub Medical booth #1 1b Straub Medical @ LINC Rotarex ® S in ISR and bypass occlusion: Are they still only a niche indication? Chair / Moderator: Romaric Loffroy

Transcript of Straub Medical @ LINCRotarex®S for in-stent restenosis/occlusion: A French multicentre experience...

  • Rotarex®S for in-stent restenosis/occlusion: A French multicentre experience with 128 patients I Romaric Loffroy

    Rotarex®S for in-stent restenosis/occlusion: The Leipzig experience with more than 300 patients I Bruno Freitas

    Live Case ISR (Leipzig)

    Clinical and cost effectiveness of treating bypass occlusion with Rotarex®S vs. surgery I Bruno Migliara

    Live Case Native Fempop (Leipzig)

    SAVioR trial: Acute improvement of vascular function following debulking atherectomy with Rotarex®S I Christos Rammos

    … for the treatment of in-stent reocclusion I Bruno Freitas I Wednesday, 09:30 – 1 1 :00

    … for the treatment of bypass occlusions I Bruno Migliara I Wednesday, 13:00 – 14:30

    www.straubmedical.com | [email protected]

    Arterial Symposium | Thursday, 09:30 – 1 1 :00 | Main Arena 1, Room 1

    Hands-on Workshop | Tips and Tricks … | @ Straub Medical booth #11b

    Straub Medical @ LINC

    Rotarex®S in ISR and bypass occlusion: Are they still only a niche indication?Chair / Moderator: Romaric Loffroy

  • P-MAX study: Iliofemoral DVT. Safety and performance update from the Arnsberg cohort I Michael Lichtenberg

    Aspirex®S in Iliofemoral DVT: The Dijon experience I Romaric Loffroy

    Aspirex®S in Iliofemoral DVT: The Maceio experience I Bruno Freitas

    Meta-analysis on thrombolysis vs. mechanical thrombectomy for iliofemoral DVT: Safety concerns should stop CDT I Michael Lichtenberg

    Safety, procedural success, and outcome of the Aspirex®S endovascular thrombectomy system in the treatment of iliofemoral deep vein thrombosis: data from the Aspirex registry I Michael Lichtenberg

    … for the treatment of Iliofemoral DVT I Romaric Loffroy I Tuesday and Thursday, 1 5 :30 – 1 7:00

    … for the treatment of occluded AVG and AVF I Jan Porod I Thursday, 1 5 :30 – 1 7:00

    Venous Symposium | Wednesday, 14 :30 – 15:00 | Global Expert Exchange Forum, Room 5

    Hands-on Workshop | Tips and Tricks … | @ Straub Medical booth #11b

    Podium Presentations | Wednesday, 13:58 – 14:19 | Global Expert Exchange Forum, Room 5

    Straub Medical @ LINC

    Aspirex®S in Iliofemoral DVT: New evidence from multiple centresChair / Moderator: Michael Lichtenberg


PERK inhibition mitigates restenosis and thrombosis - a ... · In-stent restenosis occurs in ~10–23% of coronary DES applications, and >50% in peripheral arterial diseases. Moreover,

PERK inhibition mitigates restenosis and thrombosis - a ... · In-stent restenosis occurs in ~10–23% of coronary DES applications, and >50% in peripheral arterial diseases. Moreover,

The Relation Between the Arterial Stress and Restenosis ... · the reported restenosis rate 10,24 was investigated through stent-plaque-artery interactions. Three-dimensional models

The Relation Between the Arterial Stress and Restenosis ... · the reported restenosis rate 10,24 was investigated through stent-plaque-artery interactions. Three-dimensional models

Gene therapy for in-stent restenosis: Targets and …...Gene therapy for in-stent restenosis: Targets and delivery system Kai Yin MD, Devendra K Agrawal PhD Center for Clinical & Translational

Gene therapy for in-stent restenosis: Targets and …...Gene therapy for in-stent restenosis: Targets and delivery system Kai Yin MD, Devendra K Agrawal PhD Center for Clinical & Translational

Open Access Mechanisms of Biliary Plastic Stent Occlusion ...

Open Access Mechanisms of Biliary Plastic Stent Occlusion ...

Inflammatory Growth Factors and In-Stent Restenosis ...In-stent restenosis (ISR) is defined as in-stent narrowing which more occurs in 2 months after stent implantation in coronary

Inflammatory Growth Factors and In-Stent Restenosis ...In-stent restenosis (ISR) is defined as in-stent narrowing which more occurs in 2 months after stent implantation in coronary

Photoablation and DCB in in-stent restenosis · Photoablation and DCB in in-stent restenosis Craig M. Walker, MD, FACC, FACP Clinical Professor of Medicine Tulane University School

Photoablation and DCB in in-stent restenosis · Photoablation and DCB in in-stent restenosis Craig M. Walker, MD, FACC, FACP Clinical Professor of Medicine Tulane University School

In-stent restenosis - NVHVV CarVasZ 2014/S24_1_K_Boerlage_van_Dijk.pdfBalloon in In-Stent Restenosis Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg

In-stent restenosis - NVHVV CarVasZ 2014/S24_1_K_Boerlage_van_Dijk.pdfBalloon in In-Stent Restenosis Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg

Stent thrombosis and instent restenosis: current scenario

Stent thrombosis and instent restenosis: current scenario

Role of Endothelial Shear Stress in Stent Restenosis and ...be compromised by in-stent restenosis (ISR) and stent thrombosis (ST). Several patient-specific characteristics in-cluding

Role of Endothelial Shear Stress in Stent Restenosis and ...be compromised by in-stent restenosis (ISR) and stent thrombosis (ST). Several patient-specific characteristics in-cluding

A Case of Very Early Stent Restenosis Following DES Implantation · Restenosis Following DES Implantation Ch. et al. 200 Case Report A Case of Very Early Stent Restenosis Following

A Case of Very Early Stent Restenosis Following DES Implantation · Restenosis Following DES Implantation Ch. et al. 200 Case Report A Case of Very Early Stent Restenosis Following

UvA-DARE (Digital Academic Repository) Dual …second generation drug-eluting stent (DES) placement, mainly targeting lower in-stent restenosis and stent thrombosis (ST).1,2,3,4 Although

UvA-DARE (Digital Academic Repository) Dual …second generation drug-eluting stent (DES) placement, mainly targeting lower in-stent restenosis and stent thrombosis (ST).1,2,3,4 Although

“Treatment of In-Stent Restenosis” · “Treatment of In-Stent Restenosis” J. Eduardo Sousa, MD, PhD, FACC Instituto Dante Pazzanese de Cardiologia Hospital do Coração Sao

“Treatment of In-Stent Restenosis” · “Treatment of In-Stent Restenosis” J. Eduardo Sousa, MD, PhD, FACC Instituto Dante Pazzanese de Cardiologia Hospital do Coração Sao

Drug Eluting Stent Restenosis · In-stent restenosis has been a longstanding problem after percutaneous coronary intervention. Randomized trials comparing drug-eluting stents (DES)

Drug Eluting Stent Restenosis · In-stent restenosis has been a longstanding problem after percutaneous coronary intervention. Randomized trials comparing drug-eluting stents (DES)

LONG-TERM CLINICAL OUTCOMES AFTER REPEAT DRUG-ELUTING STENT IMPLANTATION FOR IN DRUG-ELUTING STENT RESTENOSIS. C. Graidis, D. Dimitriadis, A. Ntatsios,

LONG-TERM CLINICAL OUTCOMES AFTER REPEAT DRUG-ELUTING STENT IMPLANTATION FOR IN DRUG-ELUTING STENT RESTENOSIS. C. Graidis, D. Dimitriadis, A. Ntatsios,

The Study of Intravascular Stent Design Parameters to Reduce Restenosis … · 2019-06-28 · The Study of Intravascular Stent Design Parameters to Reduce Restenosis Risk by Considering

The Study of Intravascular Stent Design Parameters to Reduce Restenosis … · 2019-06-28 · The Study of Intravascular Stent Design Parameters to Reduce Restenosis Risk by Considering

Research Club for In-stent Restenosis ( ISR club) · 2016-10-12 · Inclusion criteria • In-stent restenosis (≥50% by quantitative angiographic analysis) following all types of

Research Club for In-stent Restenosis ( ISR club) · 2016-10-12 · Inclusion criteria • In-stent restenosis (≥50% by quantitative angiographic analysis) following all types of

Patterns of in-stent restenosis after placement of NIR gold-coated …summitmd.com/pdf/syllabus/New Techniques.pdf · 2005. 3. 31. · Patterns of in-stent restenosis after placement

Patterns of in-stent restenosis after placement of NIR gold-coated …summitmd.com/pdf/syllabus/New Techniques.pdf · 2005. 3. 31. · Patterns of in-stent restenosis after placement

Carotid stenting-in stent restenosis and treatment modalities · In-stent restenosis after carotid stenting is not a trivial problem as it still exists. • Occurs less frequently

Carotid stenting-in stent restenosis and treatment modalities · In-stent restenosis after carotid stenting is not a trivial problem as it still exists. • Occurs less frequently

Your partner in complex PCI: In-stent restenosis (ISR)images.philips.com/is/content/PhilipsConsumer...Balloon for the Treatment of Coronary In-Stent Restenosis: Results From the Multi-Center

Your partner in complex PCI: In-stent restenosis (ISR)images.philips.com/is/content/PhilipsConsumer...Balloon for the Treatment of Coronary In-Stent Restenosis: Results From the Multi-Center

SeQuent Please balloon catheter for in-stent coronary restenosis

SeQuent Please balloon catheter for in-stent coronary restenosis